These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 33891901)

  • 21. Proteolysis-targeting chimeras: a kaleidoscope of targeted protein degradation.
    Mou Y; Wen S; Gao X; Jiang ZY
    Future Med Chem; 2022 Jan; 14(3):139-141. PubMed ID: 34814705
    [No Abstract]   [Full Text] [Related]  

  • 22. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Present and Future of Novel Protein Degradation Technology.
    Xia L; Liu W; Song Y; Zhu H; Duan Y
    Curr Top Med Chem; 2019; 19(20):1784-1788. PubMed ID: 31644408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel approach for characterizing ubiquitin E3 ligase function.
    Marblestone JG; Suresh Kumar KG; Eddins MJ; Leach CA; Sterner DE; Mattern MR; Nicholson B
    J Biomol Screen; 2010 Dec; 15(10):1220-8. PubMed ID: 20864734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP.
    Johansson H; Isabella Tsai YC; Fantom K; Chung CW; Kümper S; Martino L; Thomas DA; Eberl HC; Muelbaier M; House D; Rittinger K
    J Am Chem Soc; 2019 Feb; 141(6):2703-2712. PubMed ID: 30657686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
    Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
    Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
    Cowan AD; Ciulli A
    Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
    Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
    ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.
    Kaiho-Soma A; Akizuki Y; Igarashi K; Endo A; Shoda T; Kawase Y; Demizu Y; Naito M; Saeki Y; Tanaka K; Ohtake F
    Mol Cell; 2021 Apr; 81(7):1411-1424.e7. PubMed ID: 33567268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging strategies for prospective discovery of molecular glue degraders.
    Wang B; Cao S; Zheng N
    Curr Opin Struct Biol; 2024 Jun; 86():102811. PubMed ID: 38598983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery.
    Guenette RG; Potts PR
    Methods Enzymol; 2023; 681():23-39. PubMed ID: 36764759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of IAP-recruiting BCL-X
    Zhang X; He Y; Zhang P; Budamagunta V; Lv D; Thummuri D; Yang Y; Pei J; Yuan Y; Zhou D; Zheng G
    Eur J Med Chem; 2020 Aug; 199():112397. PubMed ID: 32388279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
    Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
    ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of PROTAC cooperative recognition for selective protein degradation.
    Gadd MS; Testa A; Lucas X; Chan KH; Chen W; Lamont DJ; Zengerle M; Ciulli A
    Nat Chem Biol; 2017 May; 13(5):514-521. PubMed ID: 28288108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies.
    Lucas X; Ciulli A
    Curr Opin Struct Biol; 2017 Jun; 44():101-110. PubMed ID: 28130986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
    Belcher BP; Ward CC; Nomura DK
    Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications.
    Stacey P; Lithgow H; Lewell X; Konopacka A; Besley S; Green G; Whatling R; Law R; Röth S; Sapkota GP; Smith IED; Burley GA; Harling J; Benowitz AB; Queisser MA; Muelbaier M
    SLAS Discov; 2021 Aug; 26(7):885-895. PubMed ID: 34041938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational discovery of molecular glue degraders via scalable chemical profiling.
    Mayor-Ruiz C; Bauer S; Brand M; Kozicka Z; Siklos M; Imrichova H; Kaltheuner IH; Hahn E; Seiler K; Koren A; Petzold G; Fellner M; Bock C; Müller AC; Zuber J; Geyer M; Thomä NH; Kubicek S; Winter GE
    Nat Chem Biol; 2020 Nov; 16(11):1199-1207. PubMed ID: 32747809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.